Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |